Canada markets close in 1 hour 28 minutes

BG Medicine, Inc. (BGMD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 11:36AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 545.97k
Enterprise Value 545.97k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.39
Price/Book (mrq)N/A
Enterprise Value/Revenue 0.35
Enterprise Value/EBITDA -0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 76.63
52-Week Change 30.00%
S&P500 52-Week Change 323.10%
52 Week High 30.0001
52 Week Low 30.0000
50-Day Moving Average 30.0001
200-Day Moving Average 30.0001

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 511.37M
Implied Shares Outstanding 65.46B
Float 88.31M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Aug 31, 2015) 4630.05k
Short Ratio (Aug 31, 2015) 42.66
Short % of Float (Aug 31, 2015) 410.01%
Short % of Shares Outstanding (Aug 31, 2015) 47.21%
Shares Short (prior month Jul 31, 2015) 4380.49k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jul 09, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2015
Most Recent Quarter (mrq)Dec 31, 2015

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-290.69%

Management Effectiveness

Return on Assets (ttm)-75.95%
Return on Equity (ttm)-902.64%

Income Statement

Revenue (ttm)1.57M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)-47.70%
Gross Profit (ttm)N/A
EBITDA -4.39M
Net Income Avi to Common (ttm)-6.96M
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.52M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.65
Book Value Per Share (mrq)-0.17

Cash Flow Statement

Operating Cash Flow (ttm)-3.67M
Levered Free Cash Flow (ttm)-2.11M